Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Alkaloids and derivatives |
| Classe | Camptothecins |
| Subclass | Not available |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Camptothecins |
| Alternative Parents | Hydroxyquinolines Pyranopyridines Pyridinones 1-hydroxy-2-unsubstituted benzenoids Alkylarylsilanes Tertiary alcohols Heteroaromatic compounds Lactones Lactams Carboxylic acid esters Oxacyclic compounds Organic metalloid salts Monocarboxylic acids and derivatives Azacyclic compounds Carbonyl compounds Hydrocarbon derivatives Alkylsilanes Organic oxides Organonitrogen compounds |
| Molecular Framework | Aromatic heteropolycyclic compounds |
| Substituents | Camptothecin - Hydroxyquinoline - Pyranopyridine - Quinoline - 1-hydroxy-2-unsubstituted benzenoid - Phenol - Pyridinone - Alkylarylsilane - Pyridine - Benzenoid - Heteroaromatic compound - Tertiary alcohol - Carboxylic acid ester - Lactam - Lactone - Organoheterocyclic compound - Carboxylic acid derivative - Monocarboxylic acid or derivatives - Oxacycle - Azacycle - Organic metalloid salt - Organonitrogen compound - Organic metalloid moeity - Organosilicon compound - Organic nitrogen compound - Organic oxygen compound - Organooxygen compound - Organic oxide - Hydrocarbon derivative - Carbonyl group - Alkylsilane - Alcohol - Aromatic heteropolycyclic compound |
| Description | This compound belongs to the class of organic compounds known as camptothecins. These are heterocyclic compounds comprising a planar pentacyclic ring structure, that includes a pyrrolo[3,4-beta]-quinoline moiety (rings A, B and C), conjugated pyridone moiety (ring D) and one chiral center at position 20 within the alpha-hydroxy lactone ring with (S) configuration (the E-ring). |
| External Descriptors | Not available |
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Poids moléculaire | 478.600 g/mol |
|---|---|
| XLogP3 | |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 3 |
| Exact Mass | 478.192 Da |
| Monoisotopic Mass | 478.192 Da |
| Topological Polar Surface Area | 100.000 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 982.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |
No tested/validated application protocols, assay conditions, or recommended dilutions are provided in the Product Data for this SKU. Please consult the peer-reviewed literature for protocol development appropriate to your assay type (biochemical, biophysical, or cell-based) and validate locally.
Protocol development tips (general guidance, not item-specific performance claims):
If you require a starting point, search the literature by CAS (220913-32-6) or PubChem CID (6712744) together with your assay class (e.g., “Top1 cleavage assay,” “DNA relaxation assay,” or “stability in buffer”). Validate all conditions with small-scale pilots before routine use.
The following summarizes literature knowledge about the biological role of camptothecin-class molecules and is provided for research context only. It does not constitute an item-specific performance claim and must not be interpreted as clinical guidance.
Research use boundaries: Use AR-67 strictly for in vitro/in vivo laboratory research with appropriate approvals. No medical, diagnostic, or clinical uses are intended or permitted for this catalog item.
AR-67 is not a buffering reagent. However, its behavior in buffers is important for experimental design. Guidance below is general/literature-based and not item-specific.
No validated buffer recipes or stability specifications are provided for this SKU; consult the primary literature and perform pilot stability checks by HPLC to verify the lactone/carboxylate ratio under your exact conditions.
As AR-67 is a discrete small molecule used for screening and mechanistic studies rather than a consumable solvent or bulk reagent, “green alternative” considerations focus on solvent systems and handling practices rather than replacement of the molecule itself.
Greener handling strategies (literature guidance):
Illustrative comparison for solution preparation (general):
Disposal: Collect all unused solutions and contaminated disposables as hazardous waste; avoid drain disposal. Evaluate solvent recycling programs for DMSO and alcohol blends where available.
This catalog item is supplied strictly for research use only. No medical, diagnostic, or clinical applications are supported or permitted.
Research/formulation context (general, not item-specific claims):
Regulatory notes:
Any exploration of dosage forms, toxicology, or ADME must remain within the boundaries of non-clinical laboratory investigation and institutional approvals. For any application beyond bench research, procure GMP-grade materials and follow applicable regulations; this SKU is not intended for such uses.
Item-specific physical constants were not provided in the catalog entry. Where available, consult the CoA/Spec Sheet for definitive values.
Item-specific (from Product Data):
General/literature characteristics for AR-67/camptothecin-class silylated analogs (for context only; not item specifications):
Do not treat the above literature points as specifications for this SKU. For quantitative data (mp, solubility limits, UV cutoffs, purity assays), refer exclusively to the item’s CoA/Spec Sheet and SDS.
What Moligand grade typically implies (general description; consult CoA for item-specific specifications):
What to check on receipt:
Traceability:
This product is offered as a research small molecule (screening/assay use), not primarily as a synthetic reagent. Accordingly, “reaction” use is generally out of scope. The following focuses on applications in discovery and mechanistic studies (literature-based, not item-specific performance claims):
Discovery and mechanism-of-action studies:
Analytical applications:
Note: If you intend to use AR-67 in chemical synthesis (e.g., derivatization studies), consult the primary literature for protecting-group compatibility and avoid basic conditions that compromise the E-ring lactone.
This section provides practical preparation/handling conditions relevant to AR-67 as a research compound rather than synthetic reaction recipes. All points are general/literature-based and should be validated in your lab.
Stock solution preparation:
Working solutions:
Stability monitoring:
If pursuing chemical transformations (not typical for this SKU):
Authoritative safety information resides in the product SDS; consult it before use. The catalog entry does not list GHS details for this item.
Item-specific (from Product Data):
General laboratory safety guidance for camptothecin-class research compounds (literature, not item-specific):
Waste: Collect all solutions and contaminated disposables as hazardous chemical waste following institutional cytotoxic handling policies.
Guidance below is based on the common behavior of lipophilic camptothecin analogs and is provided for planning purposes. Verify solubility empirically for your lot.
Polarity and miscibility (general/literature):
Working solution strategies:
Comparison (literature tendencies):
Always filter sterilize through PTFE or low-binding PVDF if sterile working solutions are required; confirm compound recovery to avoid adsorption losses.
Item-specific storage and shipping:
Reconstitution (general guidance; not item-specific specifications):
Stability notes (literature):
Always defer to the lot-specific CoA and SDS for definitive instructions on storage, reconstitution limits, and stability. Research Use Only.
Brief overview: AR-67 is a research small molecule in the Moligand screening library. In the open literature, AR-67 is widely described as a camptothecin-class scaffold bearing a silyl substitution that enhances lipophilicity and lactone stability. Item-specific structural identifiers provided below reflect the catalog listing; where not provided, consult the CoA/Spec Sheet.
Structural features (literature description, not item-specific specs):
2D description in words (literature): a rigid, polycyclic, planar-heteroaromatic system fused to a δ-lactone, with a distal silyl-alkyl appendage and a constrained chiral tertiary lactam center.
AR-67 is offered as a finished small molecule for screening and mechanistic studies, not as a building block. Nevertheless, camptothecin scaffolds present well-defined reactivity patterns (literature context) that may interest medicinal and synthetic chemists.
Key functional elements (literature):
Applications for method development:
Because of its structural complexity and sensitivity, AR-67 is not generally used as a synthon in multistep synthesis; rather, it is a target or reference molecule in SAR campaigns.
Only item-specific target information from the catalog may be listed here. For this SKU, no such information is provided.
General literature note (not item-specific): camptothecin-class molecules are widely studied as poisons of DNA topoisomerase I in biochemical assays. This note is provided solely for research context; it is not a validated specification for this product.
Notre guide de sélection des qualités couvre la pureté, le statut du stabilisant et l'adéquation à l'application pour toutes les variantes de notre catalogue.
Voir le guide des qualités Moligand™ →